Gene · 5916
Papers2,651
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,651
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Rare Cancer-Associated Mutations May Affect the AF1 Phosphoregulatory Domain of RARγ. | Genes (Basel) | 2026 | 42793013 | PubTator, text mining | PubMed |
| Dual HBV cccDNA-linked HiBiT reporter hepatocyte models for screening of candidate cccDNA modulators. | Virulence | 2026 | 42697841 | PubTator, text mining | PubMed |
| Stable simulations do not guarantee functional engagement: a case study of off-target prediction for Seladelpar and Zanamivir. | J Comput Aided Mol Des | 2026 | 42690469 | PubTator, text mining | PubMed |
| Genomic diversification between aposematic and cryptic phenotypes of Oophaga granulifera (Anura: Dendrobatidae). | Sci Rep | 2026 | 42661044 | PubTator, text mining | PubMed |
| Barrier Function and Biophysical Effects of 0.104% and 0.247% Retinol Creams in Mature Facial Skin: A Prospective Study. | Int J Mol Sci | 2026 | 42653210 | PubTator, text mining | PubMed |
| Trifarotene for Facial and Truncal Acne Vulgaris: A Narrative Review of Clinical Trial Evidence. | Cureus | 2026 | 42615018 | PubTator, text mining | PubMed |
| Successful Trifarotene Treatment of a Typical Kyrle's Disease With Overview of Topical Therapies. | Skin Res Technol | 2026 | 42480558 | PubTator, text mining | PubMed |
| Structural and Thermodynamic Discrimination between Agonists and Antagonists of Retinoic Acid Receptor γ and the Vitamin D Receptor. | J Chem Inf Model | 2026 | 42378554 | PubTator, text mining | PubMed |
| Am80 (tamibarotene) and ATRA induce highly similar molecular responses and myeloid differentiation in non-APL AML, enhanced by LSD1/GCN5 inhibition and increased RARA expression. | BMC Cancer | 2026 | 42365243 | PubTator, text mining | PubMed |
| Sex Differences in Cancer and Cardiotoxicity: Mechanisms, Outcomes, and Clinical Implications Across Solid and Hematological Malignancies. | Cancers (Basel) | 2026 | 42279262 | PubTator, text mining | PubMed |
| Doxorubicin-induced early-onset chronic progressive cardiotoxicity, pharmacogenetics and survival among breast cancer patients in Zimbabwe. | S Afr Med J | 2026 | 42246857 | PubTator, text mining | PubMed |
| Application of small interfering RNAs and drug combination for pancreatic cancer therapy. | J Drug Target | 2026 | 42219546 | PubTator, text mining | PubMed |
| Doxorubicin-Induced Cardiotoxicity in Breast Cancer: Mechanistic Pathways, Pharmacogenomic Modifiers, and Translational Strategies. | Cardiovasc Toxicol | 2026 | 42176227 | PubTator, text mining | PubMed |
| Heterotopic Ossification: Molecular Drivers, Subtype-Specific Mechanisms, and Translational Therapeutic Advances. | Biomolecules | 2026 | 42072706 | PubTator, text mining | PubMed |
| RARG promotes gastric cancer progression by activating PMEPA1 transcription and Wnt/β-catenin signalling. | Cell Signal | 2026 | 42025891 | PubTator, text mining | PubMed |
| Allowable robot-related material cost as a contribution margin threshold for financial sustainability of robot-assisted urologic surgery. | J Robot Surg | 2026 | 41925971 | PubTator, text mining | PubMed |
| Lamin A/C as a Molecular Link Between Nuclear Organization, Chromatin Dynamics, and Tumor Progression. | Cells | 2026 | 41892292 | PubTator, text mining | PubMed |
| Evaluation of Mass Spectrometry Compatible Reagents for Determining Small Molecule Loading in Poly(lactic acid) Nanoparticles. | Pharm Res | 2026 | 41851407 | PubTator, text mining | PubMed |
| Impaired retinoic acid receptor-γ signaling underlies a heritable form of urothelial keratinizing squamous metaplasia. | HGG Adv | 2026 | 41830175 | PubTator, text mining | PubMed |
| A Case of Unexpected Peritoneal Carcinomatosis From Colon Cancer Detected After Robot-Assisted Radical Cystectomy for Advanced Bladder Cancer. | IJU Case Rep | 2026 | 41810384 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5916/papers